V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20191545 | 20123670 | 1.67 | 94.4 | Neo-adjuvant (N) | 2017-05-31 | 2017-10-06 | Cetuximab + FOLFIRI cycle1 | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101677534 |
| 20191546 | 20123671 | 1.67 | 56 | Palliative (P) | 2018-04-20 | 2018-06-07 | Cetuximab + FOLFIRI cycle1 | N | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100150532 |
| 20191547 | 20123672 | 1.81 | 66.4 | Neo-adjuvant (N) | 2017-12-29 | 2018-02-26 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101194309 |
| 20191550 | 20123673 | 1.69 | 72.6 | Palliative (P) | 2015-12-21 | 2016-05-30 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101268965 |
| 20191562 | 20123674 | 1.59 | 94.3 | null | 2018-12-13 | 2018-12-21 | Cetuximab + FOLFIRI cycle1 | 02 | null | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101101667 |
| 20191564 | 20123675 | 1.9 | 91 | Palliative (P) | 2018-12-16 | 2019-03-16 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101754001 |
| 20191572 | 20123676 | 1.72 | 85.8 | Curative (C) | 2020-09-24 | 2020-09-28 | Cetuximab + FOLFIRI cycle 2 onwards | null | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100568216 |
| 20191573 | 20123677 | 1.67 | 78 | Palliative (P) | 2017-03-02 | 2017-03-02 | Cetuximab + FOLFIRI cycle1 | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101606884 |
| 20191574 | 20123678 | 1.69 | 82.6 | null | 2016-06-11 | 2016-06-11 | CAPECITABINE + GEMCITABINE | 02 | null | CAPECITABINE + GEMCITABINE | 101426530 |
| 20191576 | 20123679 | 1.66 | 66 | Adjuvant (A) | null | 2016-07-25 | Docetaxel 75mg/m2 (21 day) | 02 | N | DOCETAXEL | 101337448 |
| 20191578 | 20123680 | 1.81 | 53.8 | null | 2017-07-26 | 2017-07-26 | CETUXIMAB + IRINOTECAN + MDG | 02 | null | CAPECITABINE + GEMCITABINE | 101073228 |
| 20191582 | 20123681 | 1.59 | 60.8 | Palliative (P) | 2017-05-26 | 2017-06-24 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100046450 |
| 20191585 | 20123682 | 1.76 | 118 | null | 2017-11-25 | 2018-04-13 | Docetaxel | 02 | null | DOCETAXEL | 101437906 |
| 20191593 | 20123683 | 1.6 | 53.9 | Palliative (P) | 2017-11-21 | 2017-11-26 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | N | DOCETAXEL | 101233954 |
| 20191597 | 20123684 | 1.66 | null | null | 2019-05-28 | 2019-06-04 | Docetaxel 75mg/m2 (21 day) | 2 | null | DOCETAXEL | 100675612 |
| 20191601 | 20123686 | 1.84 | 66 | Palliative (P) | 2018-06-10 | 2018-06-10 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100158749 |
| 20191606 | 20123687 | 1.73 | 70 | Palliative (P) | 2018-11-03 | 2018-11-06 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100277583 |
| 20191608 | 20123688 | 1.81 | 82.8 | Palliative (P) | 2018-05-08 | 2018-05-18 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101498401 |
| 20191611 | 20123689 | 1.62 | 59 | Adjuvant (A) | 2015-10-28 | 2017-04-05 | Docetaxel 75mg/m2 (21 day) | 02 | N | DOCETAXEL | 100325348 |
| 20191612 | 20123690 | 1.61 | 57 | Palliative (P) | 2015-09-01 | 2016-08-13 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 101170112 |
| 20191613 | 20123691 | 1.88 | 60.2 | null | 2015-08-29 | 2016-11-14 | Docetaxel 75mg/m2 (21 day) | N | null | DOCETAXEL | 100566944 |
| 20191616 | 20123692 | 1.6 | 62.5 | Palliative (P) | 2019-12-01 | 2019-12-01 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100769174 |
| 20191617 | 20123693 | 1.66 | 44.1 | Neo-adjuvant (N) | 2016-06-15 | 2016-06-29 | Docetaxel 75mg/m2 (21 day) | 02 | N | DOCETAXEL | 100694014 |
| 20191624 | 20123694 | 1.88 | 65.7 | Palliative (P) | 2019-11-21 | 2019-12-11 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101662239 |
| 20191626 | 20123695 | 1.69 | 73.2 | null | 2018-08-19 | 2018-09-05 | Docetaxel 75mg/m2 (21 day) | 02 | null | DOCETAXEL | 101372246 |
| 20191632 | 20123696 | 1.66 | 74.8 | Palliative (P) | 2019-02-06 | 2019-02-07 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101439167 |
| 20191633 | 20123697 | 1.6 | 90.6 | Adjuvant (A) | 2018-06-16 | 2018-06-20 | Docetaxel | 02 | N | DOCETAXEL | 100862420 |
| 20191639 | 20123698 | 1.52 | 71.8 | Palliative (P) | 2019-12-04 | 2020-02-18 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100706192 |
| 20191644 | 20123699 | 1.54 | 65 | Palliative (P) | 2018-01-24 | 2018-01-24 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100441601 |
| 20191645 | 20123700 | 1.69 | 91.65 | Palliative (P) | 2017-02-23 | 2017-02-27 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 101253352 |
| 20191646 | 20123701 | 1.81 | 68.1 | Palliative (P) | 2020-03-31 | 2020-04-23 | CETUXIMAB + IRINOTECAN + MDG | 02 | null | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100352623 |
| 20191647 | 20123702 | 1.63 | 86 | Palliative (P) | 2017-03-13 | 2017-03-17 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100473525 |
| 20191649 | 20123703 | 1.61 | 64.1 | null | 2020-01-25 | 2020-02-11 | Gemcitabine + Capecitabine | 02 | null | CAPECITABINE + GEMCITABINE | 100907765 |
| 20191651 | 20123704 | 1.67 | 58.1 | null | 2017-04-08 | 2017-04-10 | Gemcitabine + Capecitabine | 02 | null | CAPECITABINE + GEMCITABINE | 101370331 |
| 20191654 | 20123705 | 1.67 | 54.7 | null | null | 2020-01-25 | Docetaxel | 02 | null | DOCETAXEL | 100523995 |
| 20191655 | 20123706 | 1.74 | 98 | Palliative (P) | 2019-11-21 | 2019-12-04 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101514911 |
| 20191656 | 20123707 | 1.52 | 42.9 | Adjuvant (A) | 2020-01-03 | 2020-01-03 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100653219 |
| 20191657 | 20123708 | 1.8 | 89 | Palliative (P) | 2020-02-12 | 2020-02-26 | Docetaxel 75mg/m2 (21 day) | 02 | N | DOCETAXEL | 100448505 |
| 20191658 | 20123709 | 1.63 | 66.8 | Palliative (P) | 2015-12-30 | 2017-04-26 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101484854 |
| 20191661 | 20123710 | null | 80.7 | Palliative (P) | 2020-02-07 | 2020-02-07 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100556936 |
| 20191663 | 20123711 | 1.48 | 72.6 | null | 2018-07-11 | 2018-08-06 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | null | CAPECITABINE + GEMCITABINE | 100881338 |
| 20191670 | 20123712 | 1.71 | 74.4 | null | 2018-05-15 | 2018-05-25 | Docetaxel | 02 | null | DOCETAXEL | 100975675 |
| 20191673 | 20123713 | 1.71 | 76.3 | Palliative (P) | 2019-08-27 | 2019-09-09 | Docetaxel 75mg/m2 (21 day) | 02 | N | DOCETAXEL | 100324394 |
| 20191674 | 20123714 | 1.63 | 45.2 | Palliative (P) | 2019-12-12 | 2020-01-11 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 100652806 |
| 20191676 | 20123715 | 1.67 | 66 | Palliative (P) | 2018-08-26 | 2018-09-12 | Docetaxel | 02 | N | DOCETAXEL | 101619814 |
| 20191678 | 20123716 | 1.55 | 65 | Adjuvant (A) | 2019-07-30 | 2019-08-01 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101689239 |
| 20191680 | 20123717 | 1.76 | 81.4 | Palliative (P) | 2019-11-09 | 2019-11-17 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101174049 |
| 20191682 | 20123718 | 1.72 | 71 | null | null | 2019-02-09 | CETUXIMAB + IRINOTECAN + MDG | 02 | null | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101419562 |
| 20191684 | 20123719 | null | 67.6 | null | 2017-09-28 | 2017-10-10 | Gemcitabine + Capecitabine | 02 | null | CAPECITABINE + GEMCITABINE | 101759799 |
| 20191688 | 20123720 | 1.84 | 61.5 | Palliative (P) | 2018-07-30 | 2018-08-22 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CAPECITABINE + GEMCITABINE | 101636987 |